Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma

Gene Expression

Volumn 8, Issue 5-6, 1999, Pages 341-352

  Nakashima, Ryuichi ^a,b   Song, Huijuan ^a   Enomoto, Takayuki ^b   Murata, Yuji ^b   Mcclaid, Michael R ^a   Casto, Bruce C ^a   Weghorst, Christopher M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

'Cold' SSCP; Endometrial carcinoma; Mutational analysis; TGF receptors

Indexed keywords

LIGAND; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DNA SEQUENCE; ENDOMETRIUM CARCINOMA; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH;

ACTIVIN RECEPTORS, TYPE I; ADULT; AGED; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 0033331030     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abe, T.; Guyang, H.; Migita, T.; Kato, Y.; Kimura, M.; Shiiba, K.; Sunamura, M.; Matsuno, S.; Horii, A. The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability. Eur. J Surg. Oncol. 22:474-477; 1996.
2. Baldwin, R. L.; Friess, H.; Yokoyama, M.; Lopez, M. E.; Kobrin, M. S.; Buchler, M. W.; Kore, M. Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition. Int. J. Cancer 67:283-288; 1996.
3. Bronner, C. E.; Baker, S. M.; Morrison, P. T.; Warren, G.; Smith, L. G.; Lescoe, M. K.; Kane, M.; Earabino, C.; Lipford, J.; Lindblom, A.; Tannergard, P.; Bollag, R. J.; Godwin, A. R.; Ward, D. C.; Nordenskjold, M.; Kolodner, R.; Liskay, R. M. Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature 368:258-261; 1994.
4. Chen, T.; Carter, D.; Garrigue-Antar, L.; Reiss, M. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res. 58:4805-4810; 1998.
5. Chen, T.; deVries, E. G.; Hollema, H.; Yegen, H. A.; Vellucci, V. F.; Strickler, H. D.; Hildesheim, A.; Reiss, M. Structural alterations of transforming growth factorbeta receptor genes in human cervical carcinoma. Int. J. Cancer 82:43-51; 1999.
6. Chen, Y. G.; Liu, F.; Massague, J. Mechanism of TGFbeta receptor inhibition by FKBp12. EMBO J. 16:3866-3876; 1997.
7. De, M.; Yan, W.; de Jonge, R. R.; Garrigue-Antar, L.; Vellucci, V. F.; Reiss, M. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer. Cancer Res. 58:1986-1992; 1998.
8. Duggan, B. D.; Felix, J. C.; Muderspach, L. I.; Tourgeman, D.; Zheng, J.; Shibata, D. Microsatellite instability in sporadic endometrial carcinoma. J. Natl. Cancer Inst. 86:1216-1221; 1994.
9. Enomoto, T.; Fujita, M.; Inoue, M.; Rice, J.M.; Nakajima, R.; Tanizawa, O.; Nomura, T. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res. 53:1883-1888; 1993.
10. Enomoto, T.; Inoue, M.; Perantoni, A. O.; Buzard, G. S.; Miki, H.; Tanizawa, O.; Rice, J. M. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res. 51:5308-1534; 1991.
11. Fafeur, V.; O'Hara B.; Bohlen, P. A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: Evidence for multiple growth inhibitory signal transduction pathways. Mol. Biol. Cell 4:135-144; 1993.
12. FIGO stages-1988 revision. Gynecol. Oncol. 35:125-126; 1989.
13. Fynan, T. M.; Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit. Rev. Oncog. 4:493-540; 1993.
14. Garrigue-Antar, L.; Munoz-Antonia, T.; Antonia, S. J.; Gesmonde, J.; Vellucci, V. F.; Reiss, M. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55:3982-3987; 1995.
15. Grady, W. M.; Myeroff, L. L.; Swinler, S. E.; Rajput, A.; Thiagalingam, S.; Lutterbaugh, J. D.; Neumann, A.; Brattain, M. G.; Chang, J.; Kim, S. J.; Kinzler, K. W.; Vogelstein, B.; Willson, J. K.; Markowitz, S. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59:320-324; 1999.
16. Gruber, S. B.; Thompson, W. D. A population-based study of endometrial cancer and familial risk in younger women: Cancer and Steroid Hormone Study Group. Cancer Epidemiol. Biomarkers Prev. 5:411-417; 1996.
17. Hongyo, T.; Buzard, G. S.; Calvert, R. J.; Weghorst, C. M. 'Cold SSCP': A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21:3637-3642; 1993.
18. Inoue, M.; Okayama, A.; Fujita, M.; Enomoto, T.; Sakata, M.; Tanizawa, O.; Ueshima, H. Clinicopathological characteristics of p53 overexpression in endometrial cancers, Int. J. Cancer 58:14-19; 1994.
19. Kim, I. Y.; Ahn, H. J.; Zelner, D. J.; Shaw, J. W.; Sensibar, J. A.; Kim, J. H.; Kalo, M.; Lee, C. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta I in human prostate cancer cells. Cancer Res. 56:44-48; 1996.
20. Kore, M.; Haussler, C. A.; Trookman, N. S. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res. 47:4909-4914; 1987.
21. Landis, S. H.; Murray, T.; Bolden, S.; Wingo, FI. A. Cancer statistics, 1999 (see comments). CA Cancer J. Clin. 49:8-31; 1999.
22. Lin, H. Y.; Wang, X. F.; Ng-Eaton, E.; Weinberg, R. A.; Lodish, H. F. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase Cell 68:775-785; 1992. [Published erratum appears in Cell 70(6): 1992]
23. Liu, F.; Ventura, F.; Doody, J.; Massague, J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPS. Mol. Cell. Biol. 15:3479-3486; 1995.
24. Liu, X.; Sun, Y.; Constantinescu, S. N.; Karam, E.; Weinberg, R. A.; Lodish, H. F. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA 94: 10669-10674; 1997.
25. Lu, S. L.; Akiyama, Y.; Nagasaki, H.; Saitoh, K.; Yuasa, Y. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem. Biophys. Res. Commun. 216:452-457; 1995.
26. Lu, S.-L.; Kawabata, M.; Imamura, T.; Akiyama, Y.; Nomizu, T.; Miyazono, K.; Yuasa, Y. HNPCC associated with germline mutation in the TGF-β type II receptor gene. Nat. Genet. 19:17-18; 1998.
27. Lu, S. L.; Kawabata, M.; Imamura, T.; Miyazono, K.; Yuasa, Y. Two divergent signaling pathways for TGFbeta separated by a mutation of its type II receptor gene. Biochem. Biophys. Res. Commun. 259:385-390; 1999.
28. Lynch, M. A.; Nakashima, R.; Song, H.; DeGroff, V. L.; Wang, D.; Enomoto, T.; Weghorst, C. M. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma. Cancer Res. 58:4227-4232; 1998.
29. Macias-Silva, M.; Abdollah, S.; Hoodless, P. A.; Pirone, R.; Attisano, L.; Wrana, J. L. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224; 1996.
30. Markowitz, S.; Wang, J.; Myeroff, L.; Parsons, R.; Sun, L.; Lutterbaugh, J.; Fan, R. S.; Zborowska, E.; Kinzler, K. W.; Vogelstein, B.; Brattain, M.; Willson, J. K. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338; 1995.
31. Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597-641; 1990.
32. Miyazono, K.; Ten Dijke, P.; lehijo, H.; Heldin, C. H. Receptors for transforming growth factor-beta. Adv. Immunol. 55:181-220; 1994.
33. Myeroff, L. L.; Parsons, R.; Kim, S-J.; Hedrick, L.; Cho, K. R.; Orth, K.; Mathis, M.; Kinzler, K. W.; Lutterbaugh, J.; Park, K.; Bang, Y-J.; Lee, H. Y.; Park, JG.; Lynch, H. T.; Roberts, A. B.; Vogelstein, B.; Markowitz, S. D. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:5545-5547; 1995.
34. Nakashima, R.; Fujita, M.; Enomoto, T.; Haba, T.; Yoshino, K.; Wada, H.; Kurachi, H.; Sasaki, M.; Wakasa, K.; Inoue, M.; Buzard, G.; Murata, Y. Alteration of pi6 and p!5 genes in human uterine tumours. Br. J. Cancer 80:458-467; 1999.
35. Nicolaides, N. C.; Papadopoulos, N.; Liu, B.; Wei, Y. F.; Carter, K. C.; Ruben, S. M.; Rosen, C. A.; Haseltine, W. A.; Fleischmann, R. D.; Fraser, C. M.; Adams,M. D.; Venter, J. C.; Dunlop, M. G.; Hamilton, S. R.; Petersen, G. M.; de la Chapelle, A.; Vogelstein, B.; Kinzler, K. W. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:7580; 1994.
36. Parkin, D. M.; Pisani, F.; Ferlay, J. Global cancer statistics. CA Cancer J. Clin. 49:33-64; 1999.
37. Parsons, R.; Myeroff, L. L.; Liu, B.; Willson, J. K.; Markowitz, S. D.; Kinzler, K. W.; Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55:5548-5550; 1995.
38. Pasche, B.; Luo, Y.; Rao, P. H.; Nimer, S. D.; Dmitrovsky, E.; Caron, P.; Luzzatto, L.; Offit, K.; CordonCardo, C.; Renault, B.; Satagopan, J. M.; Murty, V. V.; Massague, J. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res. 58:2727-2732; 1998.
39. Perlino, E.; Loverro, G.; Maiorano, E.; Giannini, T.; Cazzolla, A.; Napoli, A.; Fiore, M. G.; Ricco, R.; Marra, E.; Selvaggi, L. Down-regulated expression of transforming growth factor beta I mRNA in endometrial carcinoma. Br. J. Cancer 77:1260-1266; 1998.
40. Risinger, J. I.; Hayes, A. K.; Berchuck, A.; Barrett J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57:4736-4738; 1997.
41. Rose, P. G. Endometrial carcinoma [see comments]. N. Engl. J. Med. 335:640-649; 1996. [Published erratum appears in N. Engl. J. Med. 336:1335; 1997]
42. Rotello, R. J.; Lieberman, R. C.; Purchio, A. F.; Gerschenson, L. E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta I in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA 88:3412-3415; 1991.
43. Sidawy, M. R.; Silverberg, S. G. Endometrial carcinoma: Pathologic factors of therapeutic and prognostic significance. Pathol. Annu. 27:153-185; 1992.
44. Tashiro, H.; Blazes, M. S.; Wu, R.; Cho, K. R.; Bose, S.; Wang, S. I.; Li, J.; Parsons, R.; Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:3935-3940; 1997.
45. Wang, D.; Song, H.; Evans, J. A.; Lang, J. C.; Schuller, D. E.; Weghorst, C. M. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18:2285-2290; 1997.
46. Wang, J.; Han, W.; Zborowska, E.; Liang, J.; Wang, X.; Willson, J. K. V.; Sun, L.; Brattain, M. G. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271:17366-17371; 1996.
47. Wang, J.; Sun, L.; Myeroff, L.; Wang, X.; Gentry, L. E.; Yang, J.; Liang, J.; Zborowska, E.; Markowitz, S.; Willson, J. K.; Brattain, M. G. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270:22044-22049; 1995.
48. Wang, T.; Danielson, P. D.; Li, B. Y.; Shah, P. C.; Kim, S. D.; Donahoe, P. K. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling. Science 271:1120-1122; 1996.
49. Weis-Garcia, F.; Massague, J. Complementation between kinase-defective and activation-defective TGFbeta receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15:276-289; 1996.
50. Wieser, R.; Attisano, L.; Wrana, J. L.; Massague, J. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region, Mol. Cell. Biol. 13:7239-7247; 1993.
51. Wrana, J. L.; Attisano, L.; Wieser, R.; Ventura, F.; Massague, J. Mechanism of activation of the TGF-beta receptor. Nature 370:341-347; 1994.
52. Yoshinaga, K.; Sasano, H.; Furkukawa, T.; Yamakawa, H.; Yuki, M.; Sato, S.; Yajima, A.; Horii, A. The PETN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn. J. Cancer Res. 89:985-990; 1998.